The medtech giant’s diabetes unit — one of the largest diabetes tech businesses in the world — earlier this month picked up FDA clearance for its SmartGuard algorithm as an interoperable automated glycemic controller (iAGC). This enables integration with a sensor made by Abbott, designed specifically through a landmark collaboration between the companies.
MiniMed 780G, the company’s latest-generation AID system, offers meal detection technology and provides automatic adjustments and corrections to sugar levels every five minutes. This occurs for both basal (background) and bolus (mealtime) insulin needs.
Learn more about Medtronic and the rest of the diabetes space by downloading our free Diabetes Technology Special Report.
Last month, Medtronic unveiled the Instinct sensor designed specifically for its systems. Built on the Abbott FreeStyle Libre platform, Instinct reflects “the power of the partnership,” Abbott EVP, Diabetes Care, Chris Scoggins, told Drug Delivery Business News earlier this year.
The company described Instinct as the world’s smallest, thinnest, most discreet integrated CGM with a wear time of up to 15 days.
Today, the company says Instinct is now available to order with MiniMed 780G. It plans to start shipments in November.
“It’s here!” the company posted on LinkedIn. “The Instinct sensor, made by Abbott exclusively for MiniMed, is now available to order with the MiniMed 780G system. Help your patients get started today with the only AID system that delivers automated insulin 24/7 even when carb counts aren’t exact, now available with our longest wear sensor yet.”
Approval widened the addressable market for the Medtronic Diabetes business, which the company plans to separate in the next 15 months or so. The company announced in May that it planned to separate the Diabetes unit into a standalone, publicly traded company, called MiniMed.
“This milestone marks an important next step in our work to bring the proven performance and outcomes of our MiniMed 780G automated insulin delivery system to more people living with diabetes. By enabling integration with the Instinct sensor, we are advancing a smart dosing ecosystem designed to provide greater choice and flexibility, along with a more seamless experience,” said Que Dallara, EVP and president of Medtronic Diabetes and CEO-designate of MiniMed. “We’re excited to expand our ecosystem of solutions under one roof with service our customers can count on around the clock.”
